Fundraising Fox

Avak Kahvejian

InvestorFounder

General Partner at Flagship Pioneering · Co-founder, Chairman at ProFound Therapeutics · Founding Team; Founding CEO at Etiome · Chairman (Founder / founding CEO) at Abiologics

Cambridge, Massachusetts

Writes $500K – $15M checks · typically $7M

FoundedAbiologicsEtiomeProFound Therapeutics

Find your path to Avak

134 people in our graph share verified history with Avak — schools, employers, funds. One of them is your warm intro.

Anika GuptaunlockedAvak: together at Flagship Pioneering (2017–2018)
Avak: together at Cygnal Therapeutics
×8Avak: together at Flagship Pioneering
Avak: together at Cellarity

About

Avak Kahvejian, a venture investor who often serves as founding CEO of biotechs he helps create, leverages Helicos single-molecule sequencing experience to build programmable medicine platforms via internal company creation.

Invests in

AgTechAI & Machine LearningBiotechClimate TechFoodTechHealthtech

Co-founder, Chairman at ProFound Therapeutics

Intro paths

In turn, Avak can intro founders to ProFound Therapeutics's investors below.

Co-founders at ProFound Therapeutics

YE
Yann EchelardCo-founder
VM
Vini ManiCo-founder
EW
Erica WeinsteinCo-founder

Founding Team; Founding CEO at Etiome

Intro paths

In turn, Avak can intro founders to Etiome's investors below.

Co-founders at Etiome

KV
Katharine von HerrmannCo-founder
NA
Noubar AfeyanFounding Team
SLScott Lipnick
Scott LipnickFounding Team
TS
Torben Straight NissenFounding Team; Board Director
YE
Yann EchelardFounding Team; Chief Operating Officer

Chairman (Founder / founding CEO) at Abiologics

Intro paths

In turn, Avak can intro founders to Abiologics's investors below.

Co-founders at Abiologics

M
MikeChief Innovation Officer & Co-Founder
JD
Jaclyn DunphyCo-Founder & Senior Director of Strategy and Research Operations

Experience

  1. Flagship PioneeringPresident, Flagship Labscurrent2026 — presentCambridge, Massachusetts, United States
  2. Flagship PioneeringGeneral Partnercurrent2020 — present
  3. Flagship PioneeringPartner2011 — 2020Cambridge, MA
  4. EtiomeBoard Membercurrent2024 — presentCambridge, Massachusetts, United States
  5. EtiomeFounding CEO2024 — 2026
  6. Ampersand BiomedicinesChairman of the Boardcurrent2021 — presentBoston, Massachusetts, United States
  7. Ampersand BiomedicinesFounding CEO2021 — 2023Boston, Massachusetts, United States
  8. ProFound TherapeuticsChairman of the Boardcurrent2020 — present
  9. ProFound TherapeuticsFounding CEO2020 — 2023Cambridge, Massachusetts, United States
  10. CellarityBoard Membercurrent2017 — present
  11. CellarityFounding CEO2017 — 2020
  12. Ring TherapeuticsChairman of the Boardcurrent2021 — presentCambridge, Massachusetts, United States
  13. Ring TherapeuticsBoard Membercurrent2017 — present
  14. Ring TherapeuticsFounding CEO2017 — 2020
  15. AbiologicsFounding CEO and Board Member2021 — 2026Boston, Massachusetts, United States
  16. Sail BiomedicinesBoard Member2017 — 2025
  17. Sail BiomedicinesFounding CEO2017 — 2020Cambridge, Massachusetts, United States
  18. Generate Biomedicines, Inc.Board Member2018 — 2021
  19. Generate Biomedicines, Inc.Founding Co-CEO2017 — 2021Cambridge, Massachusetts, United States
  20. Cygnal TherapeuticsBoard Member2017 — 2021
  21. Cygnal TherapeuticsChief Innovation Officer2019 — 2020
  22. Cygnal TherapeuticsFounding President & CEO2017 — 2019Cambridge, Massachusetts
  23. Codiak BioSciencesMember Board Of Directors2017 — 2019Cambridge, MA
  24. Codiak BioSciencesBoard Observer2015 — 2017
  25. Rubius TherapeuticsChief Innovation Officer2017 — 2018Cambridge, Massachusetts
  26. Rubius TherapeuticsFounding President & CEO2013 — 2017Cambridge, MA
  27. Liberate DiagnosticsVice President, Business Development2011Cambridge, MA
  28. Helicos BioSciencesVice President, Business Development2010 — 2011
  29. Helicos BioSciencesDirector of Business Development2009 — 2010
  30. Helicos BioSciencesProduct Manager2004 — 2009
  31. PerSeptive BioSystemsProduct Evaluation Lab Associate1996

Skills & more

Biotechnology87Lifesciences42Start-ups63Commercialization28Molecular Biology18Genomics22R&D16Product Development7Strategic Planning9Drug Discovery6Medical Devices14Business Development27
+12 moreSalesProduct ManagementProject ManagementCross-functional Team LeadershipEntrepreneurshipBioinformaticsBiopharmaceuticalsDNAMolecular DiagnosticsSequencingLife SciencesResearch and Development (R&D)

Languages Armenian · English · French

From Avak's professional profile.

Colleagues at Flagship Pioneering

Network1

Investors connected to Avak in public investor directories — a warm-intro map.

Frequently asked questions

Who is Avak Kahvejian?
Avak Kahvejian, a venture investor who often serves as founding CEO of biotechs he helps create, leverages Helicos single-molecule sequencing experience to build programmable medicine platforms via internal company creation.
Where does Avak Kahvejian work?
Avak Kahvejian is Chairman (Founder / founding CEO) of Abiologics and General Partner at Flagship Pioneering and Co-founder, Chairman at ProFound Therapeutics and Founding Team; Founding CEO at Etiome.
What does Avak Kahvejian invest in?
Avak Kahvejian invests in AgTech, AI & Machine Learning, Biotech, Climate Tech, FoodTech, Healthtech.
What check size does Avak Kahvejian write?
Avak Kahvejian typically writes checks of $500K – $15M.
What companies did Avak Kahvejian found?
Avak Kahvejian founded Abiologics, Etiome, ProFound Therapeutics.
Where did Avak Kahvejian go to school?
Avak Kahvejian studied at McGill University (Ph.D., Biochemistry); McGill University (B.Sc., Biochemistry); Marianopolis College (DEC, General Sciences).

Founder mafias

McGill University mafia208

Also came through, then founded or led a company.

+ 201 more

Flagship Pioneering mafia21

Also came through, then founded or led a company.

+ 14 more

Marianopolis College mafia14

Also came through, then founded or led a company.

+ 7 more

Cellarity mafia4

Also came through, then founded or led a company.

Codiakbio mafia4

Also came through, then founded or led a company.

Same school

Shared employers